Adherence to somatostatin analog therapy for acromegaly
The main goals of treatment for many diseases are to improve the prognosis of diseases and to enhance the quality of life. Among the barriers that restrict achieving these goals we have to mention adherence to treatment. Patients with chronic diseases, including acromegaly, are at increased risk of...
Main Author: | I. A. Ilovayskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-05-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6130 |
Similar Items
-
Long-term Primary Medical Therapy with Somatostatin Analogs in Acromegaly
by: Deng-Huang Su
Published: (2006-01-01) -
Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis
by: Michelle H. Gurel, et al.
Published: (2017-04-01) -
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
by: Sang Ouk Chin, et al.
Published: (2019-03-01) -
Novel Somatostatin Receptor Ligands Therapies for Acromegaly
by: Rosa Maria Paragliola, et al.
Published: (2018-03-01) -
Acromegaly: Beyond surgery
by: Gaya Thanabalasingham, et al.
Published: (2013-01-01)